Stage IV Melanoma Completed Phase 1 Trials for Interferon alfa-2b (DB00105)

IndicationStatusPhase
DBCOND0028660 (Stage IV Melanoma)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00217542Azacitidine and Recombinant Interferon Alfa-2b in Treating Patients With Stage III or Stage IV Melanoma or Stage IV Kidney Cancer That Cannot Be Removed By SurgeryTreatment
NCT00498979Sodium Stibogluconate and IFNa-2b Followed By CDDP, VLB and DTIC Treating Pts.With Advanced Melanoma or Other CancersTreatment